Trademark: 97452965
Status Date
Thursday, October 19, 2023
Filing Date
Friday, June 10, 2022
Published for Opposition
Tuesday, April 4, 2023
5 Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use
Apr 11, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 11, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 19, 2023
Sou Extension 1 Granted
Oct 19, 2023
Sou Extension 1 Filed
Oct 19, 2023
Sou Teas Extension Received
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 24, 2023
Approved For Pub - Principal Register
Feb 16, 2023
Examiner's Amendment Entered
Feb 16, 2023
Notification Of Examiners Amendment E-Mailed
Feb 16, 2023
Examiners Amendment E-Mailed
Feb 16, 2023
Examiners Amendment -Written
Feb 15, 2023
Assigned To Examiner
Jun 14, 2022
New Application Office Supplied Data Entered
Jun 14, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
